semaglutide dose progression Wegovy Dosing Schedule Semaglutide 5mg/ml dosage chart: complete

In the placebo-controlled studies (STEP 1 to STEP 4), SAEs occurred in 8% to 10% of patients in the semaglutide group and in 3% to 9% of patients in the placebo group

No, ispaghula husk should not replace established diabetes therapies

Type 2 Diabetes and Obesity are complex medical conditions, and medication coverage should reflect a documented clinical and appropriate need

Red flag symptoms requiring urgent medical attention include: Severe abdominal pain , particularly if constant, progressively worsening, or localized to a specific area Persistent vomiting lasting more than 24 hours or containing blood Signs of pancreatitis : severe upper abdominal pain radiating to the back, often accompanied by nausea and vomiting Right upper quadrant pain, fever, or yellowing of skin/eyes , which may indicate gallbladder disease (a known risk with GLP-1 RAs) [7] [11] Severe, persistent constipation with abdominal distension and vomiting , which could suggest ileus (intestinal obstruction) Inability to pass gas or stool , severe bloating, cramping pain Unexplained weight loss beyond expected therapeutic effects Difficulty swallowing or sensation of food getting stuck Black, tarry stools or blood in stool , which may indicate gastrointestinal bleeding Call 911 or seek emergency care for severe, worsening abdominal pain, signs of gastrointestinal bleeding, or inability to keep fluids down for more than 24 hours with signs of dehydration

The study was performed in compliance with the principles of the Declaration of Helsinki, the International Conference on Harmonization for Good Clinical Practice Guideline, and applicable regulatory requirements